Abstract
Purpose
Systemic review to compare selective laser trabeculoplasty (SLT) to other glaucoma treatment options in terms of their intraocular pressure (IOP)-lowering effect.
Methods
Searches of the following databases were performed: PubMed, Cochrane Central Register of Controlled Trials, Ovid, EMBASE, metaRegister of Controlled Trials, and ClinicalTrials.gov. Only randomised controlled trials (RCTs) published in peer-reviewed journals comparing SLT to other glaucoma treatment options were considered. The main outcome measure was the change in IOP from baseline.
Results
An initial search of PubMed identified 23 RCTs with 17 meeting the inclusion criteria. Nine RCTs compared 180° SLT to 180° argon laser trabeculoplasty (ALT) and one trial compared 360° SLT to 360° ALT, all reporting no difference in terms of IOP reduction from baseline. One RCT reported better outcomes with SLT at 1 year but this effect regressed at 2 years. Three trials compared 360° SLT to medical therapy and found no difference between the two treatment options. One trial found greater IOP reduction with latanoprost vs 90° and 180° SLT, and greater IOP reduction with 180° and 360° SLT versus 90° SLT, however no differences were found between 360° SLT versus latanoprost or 360° vs 180° SLT. Two trials compared 180° SLT to 360° SLT finding no difference in IOP reduction. Two trials compared 180° SLT to 90° SLT, one finding no significant difference and one finding greater IOP reduction with 180° SLT over 90° SLT. One trial compared excimer laser trabeculotomy (ELT) to 180° SLT, finding no differences in IOP reduction up to 3 months follow-up but greater IOP reduction with ELT at time intervals between 9 and 24 months. There were no RCTs identified that compared SLT to surgery.
Conclusion
In terms of the IOP lowering effect, there is no difference between SLT and ALT. Three trials indicate no difference between 360° SLT and medical therapy, with one of the trials indicating greater IOP reduction with latanoprost over 90° and 180° SLT. Three trials indicate no difference between 180° SLT and 360° SLT. It is inconclusive whether 90° is less efficacious than 180° SLT. One trial reports greater IOP reduction with ELT over 180° SLT in the long term.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pascolini D, Mariotti SP . Global estimates of visual impairment: 2010. Br J Ophthalmol 2012; 96: 614–618.
Khaw PT, Shah P, Elkington AR . Glaucoma—1: diagnosis. BMJ 2004; 328: 97–99.
Latina MA, Park C . Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995; 60: 359–371.
Anderson RR, Parrish JA . Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524–527.
Van Buskirk EM, Pond V, Rosenquist RC, Acott TS . Argon laser trabeculoplasty. Studies of mechanism of action. Ophthalmology 1984; 91: 1005–1010.
Kramer TR, Noecker RJ . Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001; 108: 773–779.
Cvenkel B, Hvala A, Drnovsek-Olup B, Gale N . Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med 2003; 33: 204–208.
Bozkurt E, Kara N, Yazici AT, Yuksel K, Demirok A, Yilmaz OF et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2011; 152: 976–981 e972.
Realini T, Charlton J, Hettlinger M . The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging 2010; 41: 100–103.
Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y . Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol 2005; 89: 1157–1160.
Gracner T . Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol 2002; 12: 287–292.
Cellini M, Leonetti P, Strobbe E, Campos EC . Matrix metalloproteinases and their tissue inhibitors after selective laser trabeculoplasty in pseudoexfoliative secondary glaucoma. BMC Ophthalmol 2008; 8: 20.
Agarwal HC, Poovali S, Sihota R, Dada T . Comparative evaluation of diode laser trabeculoplasty vs frequency doubled Nd: YAG laser trabeculoplasty in primary open angle glaucoma. Eye (Lond) 2006; 20: 1352–1356.
Best UP, Domack H, Schmidt V . [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty—a controlled prospective clinical trial on 284 eyes]. Klin Monbl Augenheilkd 2007; 224: 173–179.
Popiela G, Muzyka M, Szelepin L, Cwirko M, Nizankowska MH . [Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma]. Klin Oczna 2000; 102: 129–133.
Chen E, Golchin S, Blomdahl S . A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma 2004; 13: 62–65.
Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, Matilla M, Macias JM, Benitez-del-Castillo JM et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye (Lond) 2004; 18: 498–502.
McAlinden C, Khadka J, Pesudovs K . Statistical methods for conducting agreement (comparison of clinical tests) and precision (repeatability or reproducibility) studies in optometry and ophthalmology. Ophthalmic Physiol Opt 2011; 31: 330–338.
Russo V, Barone A, Cosma A, Stella A, Delle Noci N . Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. Eur J Ophthalmol 2009; 19: 429–434.
Goyal S, Beltran-Agullo L, Rashid S, Shah SP, Nath R, Obi A et al. Effect of primary selective laser trabeculoplasty on tonographic outflow facility: a randomised clinical trial. Br J Ophthalmol 2010; 94: 1443–1447.
Nagar M, Luhishi E, Shah N . Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol 2009; 93: 497–501.
Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG . Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol 1999; 83: 718–722.
Damji KF, Bovell AM, Hodge WG, Rock W, Shah K, Buhrmann R et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol 2006; 90: 1490–1494.
Bovell AM, Damji KF, Hodge WG, Rock WJ, Buhrmann RR, Pan YI . Long term effects on the lowering of intraocular pressure: selective laser or argon laser trabeculoplasty? Can J Ophthalmol 2011; 46: 408–413.
Birt CM . Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Can J Ophthalmol 2007; 42: 715–719.
Rosenfeld E, Shemesh G, Kurtz S . The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients. Clin Ophthalmol 2012; 6: 1935–1940.
Liu Y, Birt CM . Argon versus selective laser trabeculoplasty in younger patients: 2-year results. J Glaucoma 2012; 21: 112–115.
Lai JS, Chua JK, Tham CC, Lam DS . Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol 2004; 32: 368–372.
Nagar M, Ogunyomade A, O'Brart DP, Howes F, Marshall JA . randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 2005; 89: 1413–1417.
Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G . SLT/Med Study Group. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma 2012; 21 (7): 460–468.
Vogel M, Lauritzen K . [Selective excimer laser ablation of the trabecular meshwork. Clinical results]. Ophthalmologe 1997; 94: 665–667.
Walker R, Specht H . [Theoretical and physical aspects of excimer laser trabeculotomy (ELT) ab interno with the AIDA laser with a wave length of 308 mm]. Biomed Tech (Berl) 2002; 47: 106–110.
Babighian S, Caretti L, Tavolato M, Cian R, Galan A . Excimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open-angle glaucoma. A 2-year randomized, controlled trial. Eye (Lond) 2010; 24: 632–638.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
McAlinden, C. Selective laser trabeculoplasty (SLT) vs other treatment modalities for glaucoma: systematic review. Eye 28, 249–258 (2014). https://doi.org/10.1038/eye.2013.267
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2013.267
Keywords
This article is cited by
-
Intraocular pressure-lowering effects of ripasudil, a rho-kinase inhibitor, and selective laser trabeculoplasty as adjuvant therapy in patients with uncontrolled glaucoma
International Ophthalmology (2021)
-
10-year outcomes of first-line selective laser trabeculoplasty (SLT) for primary open-angle glaucoma (POAG)
Graefe's Archive for Clinical and Experimental Ophthalmology (2021)
-
A comprehensive map of disease networks and molecular drug discoveries for glaucoma
Scientific Reports (2020)
-
Selective laser trabeculoplasty as the primary treatment for open angle glaucoma: time for change?
Eye (2020)
-
Evaluation of the effects of selective laser trabeculoplasty on anterior segment parameters by anterior segment optical coherence tomography
Lasers in Medical Science (2020)
